Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) Short Interest Update

Bullfrog AI Holdings, Inc. (NASDAQ:BFRG) was the target of a significant decline in short interest in the month of February. As of February 28th, there was short interest totalling 543,400 shares, a decline of 28.2% from the February 13th total of 756,800 shares. Currently, 8.7% of the shares of the company are sold short. Based on an average trading volume of 860,500 shares, the short-interest ratio is currently 0.6 days.

Bullfrog AI Price Performance

Shares of BFRG traded up $0.13 during trading hours on Friday, hitting $1.72. The company’s stock had a trading volume of 135,474 shares, compared to its average volume of 319,904. The company has a market cap of $14.99 million, a price-to-earnings ratio of -2.02 and a beta of 0.32. The business has a 50 day simple moving average of $2.45 and a two-hundred day simple moving average of $2.41. Bullfrog AI has a 52-week low of $1.43 and a 52-week high of $4.84.

Bullfrog AI (NASDAQ:BFRG) last announced its quarterly earnings data on Friday, March 14th. The company reported ($0.18) earnings per share for the quarter.

Institutional Trading of Bullfrog AI

A number of institutional investors and hedge funds have recently bought and sold shares of the company. Geode Capital Management LLC grew its stake in shares of Bullfrog AI by 31.0% in the fourth quarter. Geode Capital Management LLC now owns 47,093 shares of the company’s stock worth $94,000 after acquiring an additional 11,140 shares during the period. Raymond James Financial Inc. purchased a new position in Bullfrog AI during the fourth quarter valued at approximately $30,000. Finally, Two Sigma Securities LLC purchased a new position in Bullfrog AI during the fourth quarter valued at approximately $41,000. 0.96% of the stock is currently owned by institutional investors.

About Bullfrog AI

Bullfrog AI Holdings, Inc, through its subsidiaries, operates as a digital biopharmaceutical company that focuses on artificial intelligence and machine learning (AI/ML) driven analysis of data sets in medicine and healthcare in the United States. The company offers bfLEAP, an analytical AI/ML platform for the analysis of preclinical and/or clinical data.